References
- Geroulanos S, Marathias K, Kriaras J, Kadas B. Cephalosporins in surgical prophylaxis. J Chemother 2001; 13 Spec No 1: 23-26.
- Song F, Glenny AM. Antimicrobial prophylaxis in col-orectal surgery: a systematic review of randomised controlled trials. Health Technol Assess 1998; 2: 1–110.
- Dietrich ES, Bieser U, Frank U, Schwarzer G, Daschner FD. Ceftriaxone versus other cephalosporins for perioperative antibiotic prophylaxis: a meta-analysis of 43 randomized con-trolled trials. Chemotherapy 2002; 48: 49–56.
- Da Costa A, Kirkorian G, Cucherat M et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta analysis. Circulation 1998; 97: 1796–1801.
- Gillespie WJ, Walenkamp G. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone frac-tures. Cochrane Database Syst Rev 2001; (1): CD000244.
- Mini E, Grassi F, Cherubino P, Nobili S, Periti P. Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery. J Chemother 2001; 13 Spec No 1: 73-79.
- Esposito S, Novelli A, de Lalla F. Antibiotic prophylaxis in surgery: news and controversies. Infez Med 2002; 10: 131–144.
- Wise R. B-lactams: cephalosporins. In: O'Grady F, Lambert HP, Finch RG, Greenwood D, Eds. Antibiotic and Chemotherapy: anti-infective agents and their use in chemotherapy, 7th edn. Churchill Livingstone New York: 1997; 202-255.
- Esposito S, Noviello S, Vanasia A, Venturino P. Ceftriaxone versus other antibiotics for surgical prophylaxis. A meta-analysis. Clin Drug Invest 2004; 24: 29–39.
- Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med 1993; 153: 1581–1586.
- Terpstra S, Noordhoek GT, Voesten HG, Hendriks B, Degener JE. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J Hosp Infect 1999; 43: 195–202.
- Edlund C, Stark C, Nord CE. The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. J Antimicrob Chemother 1994; 34: 127–138.
- Esposito S, Capuano A, Noviello S et al. Modification of patients' endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. J Chemother 2003; 15: 568–573.
- Dancer SJ. The problem with cephalosporins. J Antimicrob Chemother 2001; 48: 463–478.
- Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylax-is. J Infect Dis 1983; 147: 642–649.
- Kernodle DS, Barg NL, Kaiser AB. Low-level coloniza-tion in hospitalized patients with methicillin-resistant coagu-lase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother 1988; 32: 202–208.
- Jones RN. The current and future impact of antimicro-bial resistance among nosocomial bacterial pathogens. Diagn Microbiol Infect Dis 1992; 15 (2 Suppl): 3S-10S.
- Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999; 27: 1421-1428.
- Davey P, Malek M, Thomas P. Measuring the cost-effectiveness of antibiotic prophylaxis in surgery. Am J Surg 1992; 164 (4A Suppl): 39S-43S.
- Mecchia P. Comparative study of ceftriaxone versus cefazolin plus clindamycin as antibiotic prophylaxis in elective colorectal surgery. J Chemother 2000; 12 Suppl 3: 5–9.
- Zanella E, Rulli F. A multicenter randomized trial of prophylaxis with intravenous cefepime + metronidazole or cef-triaxone + metronidazole in colorectal surgery. The 230 Study Group. J Chemother 2000; 12: 63–71.
- Kernodle DS, Kaiser AB. Post-operative infections and antimicrobial prophylaxis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone. 1995: 2742–2756.
- Woodfield JC, Van Rij AM, Pettigrew RA, van der Linden AJ, Solomon C, Bolt D. A comparison of the prophy-lactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. Am J Surg 2003; 185; 45–49.
- Grazi GL, Mazziotti A, Fisichella S, Scalzi E, Cavallari A. Antimicrobial prophylaxis with ceftriaxone for prevention of early postoperative infections after 49 liver transplantations. J Chemother 2000; 12 Suppl 3: 10–16.
- Ross CB, Wheeler WG 2nd, Jones MJ, Kerins CA, Peek TE. Ceftriaxone versus cefazolin in peripheral arterial operations: a randomized, prospective trial. South Med J 1997; 90: 16–22.
- Chen J, Gutkin Z, Bawnik J. Postoperative infections in breast surgery. J Hosp Infect 1991; 17: 61–65.
- de Lalla F. Antibiotic prophylaxis in orthopaedic pros-thetic surgery. J Chemother 2001; 13 Spec No 1: 48-53.
- Mazza A. Ceftriaxone as short-term antibiotic prophy-laxis in orthopedic surgery: a cost-benefit analysis involving 808 patients. J Chemother 2000; 12 Suppl 3: 29–33.
- Periti P, Stringa G, Mini E. Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylax-is in prosthetic joint implant surgery. Italian Study Group for Antimicrobial Prophylaxis in Orthopaedic Surgery. Eur J Clin Microbiol Infect Dis 1999; 18: 113–119.
- van Ek B, Dijkmans BA, van Dulken H, Mouton RP, Hermans J, van Furth R. Effect of cloxacillin prophylaxis on the bacterial flora of craniotomy wounds. Scand J Infect Dis 1990; 22: 345–352.
- Kumari P, Tyagi A, Marks P, Kerr KG. Corynebacterium afermentans spp. afermentans sepsis in a neurosurgical patient. J Infect 1997; 35: 201–202.
- Jallo GI, Koslow M, Hanna BA, Carson LA. Propionibacterium as a cause of postneurosurgical infection in patients with dural allografts: report of three cases. Neurosurgery 1999; 44: 1138–1141.
- Cacciola F, Cioffi F, Anichini P, Di Lorenzo N. Antibiotic prophylaxis in clean neurosurgery. J Chemother 2001; 13 Spec No 1: 119-122.
- Zhu XL, Wong WK, Yeung WM et al. A randomized, double-blind comparison of ampicillin/sulbactam and ceftriax-one in the prevention of surgical-site infections after neuro-surgery. Clin Ther 2001; 23: 1281–1291.
- Brodgen RN, Ward A. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs 1988; 35: 604–645.
- Knapp CC, Sierra-Madero J, Washington JA. Antibacterial activities of cefpodoxime, cefixime, and ceftriax-one. Antimicrob Agents Chemother 1988; 32: 1896–1898.
- Smith MA, Alperstein P, France K, Vellozzi EM, Isenberg HD. Susceptibility testing of Propionibacterium acnes comparing agar dilution with E test. J Clin Microbiol 1996; 34: 1024–1026.
- Karlowsky JA, Jones ME, Mayfield DC, Thornsberry C, Sahm DF. Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network (TSN) Database-USA. Int J Antimicrob Agents 2002; 19: 413–426.
- Martin C, Cottin A, Francois-Godfoy N et al. Concentrations of prophylactic ceftriaxone in abdominal tis-sues during pancreatic surgery. J. Antimicrob Chemother 1997; 40: 445–448.
- Martin C, Viviand X, Coffin A et al. Concentrations of ceftriaxone (1,000 milligrams intravenously) in abdominal tis-sues during open prostatectomy. Antimicrob Agents Chemother 1996; 40: 1311–1313.
- Leone M, Albanese J, Tod M et al. Ceftriaxone (1 g intravenously) penetration into abdominal tissues when admin-istered as antibiotic prophylaxis during nephrectomy. J Chemother 2003; 15: 139–142.
- Steib A, Jacoberger B, Von Bandel M et al. Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation. Antimicrob Agents Chemother 1993; 37: 1873–1876.
- Martin M, Viviand X, Alaya M et al. Penetration of cef-triaxone (1 or 2 grams intravenously) into mediastinal and car-diac tissues in humans. Antimicrob Agents Chemother 1996; 40: 812–815.
- Scaglione F, De Martini G, Peretto L et al. Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty. Antimicrob Agents Chemother 1997; 41: 2292–2294.
- Lovering AM, Walsh TR, Bannister GC, MacGowan AP. The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone. J Antimicrob Chemother 2001; 47: 483–486.
- Lang R, Folman Y, Ravid M, Bental T, Gepstein R. Penetration of ceftriaxone into the intervertebral disc. J Bone Joint Surg Am 1994; 76: 689–691.
- Anderson G, Boldiston C, Woods S, O'Brien P. A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery. Arch Surg 1996; 131: 744–748.
- Mittelkötter U, Rau HG, Thiede A, Schildberg FW, Kullmann KH. Perioperative antimicrobial prophylaxis for colonic surgery: Present status in Germany. A prospective multicentre study with and without Metronidazole. Zentralbl Chir 2001; 126: 799–804.
- Rau HG, Mittelkötter U, Zimmermann A, Lachmann A, Kohler L, Kullmann KH. Perioperative infection prophylaxis and risk factor impact in colon surgery. Chemotherapy 2000; 46: 353–363.
- Dormann AJ, Wigginghaus B, Risius H et al. A single dose of ceftriaxone administered 30 minutes before percuta-neous endoscopic gastrostomy significantly reduces local and systemic infective complications. Am J Gastroenterol 1999; 94: 3220–3224.
- Dormann AJ, Wigginghaus B, Risius H et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG) - results from a prospective randomized multicenter trial. Z Gastroenterol 2000; 38: 229–234.
- Farello GA, Cerofolini A. Antimicrobial prophylaxis with ceftriaxone in laparoscopic cholecystectomy: a 7-year clinical experience involving 3,603 patients. J Chemother 2000; 12 Suppl 3: 17–22.
- Lippert H, Gastinger J. Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy. Conclusions of a large prospective multicenter quality assurance study in Germany. Chemotherapy 1998; 44: 355–363.
- Montorsi W, Germiniani R. Pefloxacin versus ceftriax-one in single-dose antibiotic prophylaxis in general clean-cont-aminated surgery. The Pefloxacin Study Group. Minerva Chir. 1997; 52: 1539-1548. Gulberg V, Delbert P, Ochs A, Rossle M, Gerbes AL. Prevention of infectious complications after transjugular intra-hepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone. Hepatogastroenterology 1999; 46: 1126–1130.
- Li ZL, Tong SX, Yu BM et al. Single-dose ceftriaxone versus multiple-dose cefuroxime for prophylaxis of surgical site infection. Zhonghua Wai Ke Za Zhi 2003; 41: 372–374.
- Conan Doyle Sir A. In ‘The Devil's Foot’, The Strand Magazine 1910; Vol 40.
- Hell K. How to choose antimicrobials for surgical pro-phylaxis. J Chemother 1989; 1: 24–29.
- Hall JC, Hall JL. Antibiotic prophylaxis for patients undergoing breast surgery. J Hosp Infect 2000; 46: 165–170.
- Gupta R, Sinnett D, Carpenter R, Preece PE, Royle GT. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur J Surg Oncol 2000; 26: 363–366.
- Kriaras I, Michalopoulos A, Turina M, Geroulanos S. Evolution of antimicrobial prophylaxis in cardiovascular surgery. Eur J Cardiothorac Surg 2000; 18: 440–446.
- Salminen US, Viljanen TU, Valtonen VV, Ikonen TE, Sahlman AE, Harjula AL. Ceftriaxone versus vancomycin pro-phylaxis in cardiovascular surgery. J Antimicrob Chemother 1999; 44: 287–290.
- Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–1673.
- Ilic N, Petricevic A, Kotarac S, Perisic R. Single-dose ceftriaxone versus multiple-dose cefuroxime for antimicrobial chemoprophylaxis in pleuropulmonary surgery. Panminerva Med 1997; 39: 240–243.
- Thomas R, Alvino P, Cortino GR et al. Long-acting versus short-acting cephalosporins for preoperative prophylax-is in breast surgery: A randomized double-blind trial involving 1,766 patients. Chemotherapy 1999; 45: 217–223.
- Elia S, Gentile M, Guggino G, Marcone GR, Ferraro A, Ferrante G. Preoperative antimicrobial prophylaxis with a long-acting cephalosporin for thoracic surgery in 192 non small cell lung cancer patients. J Chemother 1998; 10: 58–63.
- Truesdale R, D'Alessandri R, Manuel V, Daicoff G, Kluge RM. Antimicrobial vs placebo prophylaxis in noncardiac thoracic surgery. JAMA 1979; 241: 1254–1256.
- Cameron JL, Imbembo A, Kieffer RF, Spray S, Baker RR. Prospective clinical trial of antibiotics for pulmonary resections. Surg Gynecol Obstet 1981; 152: 156–158. Antipas G, Koburas C, Andrikopoulos B, Kavoukas St. Kakkaris. Prophylactic antibiotics in chest surgery. Comparison between cefuroxime and ampicillin. Proc IV Mediterranean Congr Chemother, Rhodos, Greece, 19-25 October 1984. Chemioterapia 1985; 4 (Suppl 2): 788-789.
- Turna A, Kutlu CA, Ozalp T, Karamustafaoglu A, Mulazimoglu L, Bedirhan MA. Antibiotic prophylaxis in elec-tive thoracic surgery: cefuroxime versus cefepime. Thorac Cardiovasc Surg 2003; 51: 84–88.
- Morimoto K, Koh M, Kinoshita H. Levofloxacin for prophylaxis in breast cancer surgery compared with ofloxacin. Jpn J Antibiot 2002; 55: 866–874.
- Leaper DJ. Prophylactic and therapeutic role of antibi-otics in wound care. Am J Surg 1994; 167 (1A): 15S-19S.
- Wilcox MH, Hall J, Pike H et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003; 54: 196–201.
- Boxma H, Broekhuizen T, Patka P, Oosting H. Randomised controlled trial of single-dose antibiotic prophylax-is in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet 1996; 347 (9009): 1133–1137.
- Luthje P, Nurmi I, Aho H et al. Single-dose antibiotic prophylaxis in osteosynthesis for hip fractures. A clinical multicentre study in Finland. Ann Chir Gynaecol 2000; 89: 125–130.
- Whitby M, Johnson BC, Atkinson RL, Stuart G. The comparative efficacy of intravenous cefotaxime and trimetho-prim/sulfamethoxazole in preventing infection after neuro-surgery: a prospective, randomized study. Brisbane Neurosurgical Infection Group. Br J Neurosurg 2000; 14: 13–18.
- Young RF, Lawner PM. Perioperative antibiotic prophy-laxis for prevention of postoperative neurosurgical infections. A randomized clinical trial. J Neurosurg 1987; 66: 701–705.
- Bullock R, van Dellen JR, Ketelbey W, Reinach SG. A double-blind placebo-controlled trial of perioperative prophy-lactic antibiotics for elective neurosurgery. J Neurosurg 1988; 69: 687–691.
- Djindjian M, Lepresle E, Homs JB. Antibiotic prophy-laxis during prolonged clean neurosurgery. Results of a ran-domized double-blind study using oxacillin. J Neurosurg 1990; 73: 383–386.
- Gaillard T, Gilsbach JM. Intra-operative antibiotic pro-phylaxis in neurosurgery. A prospective, randomized, con-trolled study on cefotiam. Acta Neurochir (Wien) 1991; 113: 103–109.
- Bidzinski J, Barczewska M, Marchel A. Ceftriaxone (Rocephin “Roche”) in short-term program of perioperationalprophylaxis in neurosurgery. Neurol Neurochir Pol 1993; 27: 55–61.
- Zentner J, Gilsbach J, Felder T. Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients. Neurosurg Rev 1995; 18: 169–172.
- Zhao JZ, Wang S, Li JS et al. The perioperative use of ceftriaxone as infection prophylaxis in neurosurgery. Clin Neurol Neurosurg 1995; 97: 285–289.
- Arnaboldi L. Antimicrobial prophylaxis with ceftriaxone in neurosurgical procedures. A prospective study of 100 patients undergoing shunt operations. Chemotherapy 1996; 42: 384–390.
- Holloway KL, Smith KW, Wilberger JE Jr, Jemsek JG, Giguere GC, Collins JJ. Antibiotic prophylaxis during clean neurosurgery: a large, multicenter study using cefuroxime. Clin Ther 1996; 18: 84–94.
- Schnoring M, Brock M. Prophylactic antibiotics in lum-bar disc surgery: analysis of 1,030 procedures. Zentralbl Neurochir 2003; 64: 24–29.
- Barker FG II. Efficacy of prophylactic antibiotics for craniotomy: a meta-analysis. Neurosurgery 1994; 35: 484–492.
- Barker FG II. Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis. Neurosurgery 2002; 51: 391–401.
- Korinek AM. Risk factors for neurosurgical site infec-tions after craniotomy: a prospective multicenter study of 2944 patients. The French Study Group of Neurolosurgical Infections, the SEHP, and the C-CLIN Paris-Nord. Service Epidemiologie Hygiene et Prevention. Neurosurgery 1997; 41: 1073–1081.
- Scholz M, Luftenegger W, Harmuth H, Wolf D, Holtl W. Single-dose antibiotic prophylaxis in transurethral resection of the prostate: a prospective randomized trial. Br J Urol 1998; 81: 827–829.
- Gervino L, Cangioni G, Renzi F. A retrospective study on the efficacy of short-term perioperative prophylaxis in abdominal surgery for hernia repair in 1,254 patients. J Chemother 2000; 12 Suppl 3: 34–37.
- Campobasso P. Antibiotic prophylaxis in pediatric surgery of genito-urinary abnormalities. Infez Med 2002; 10: 88–92.
- Ruol A, Bertiato G, Boscarin S et al. Short-term pro-phylaxis with ceftriaxone plus metronidazole in esophageal cancer surgery. J Chemother 2000; 12 Suppl 3: 23–28.
- Schmidt-Matthiesen A, Roding H, Windolf J et al. A prospective, randomised comparison of single- vs. multiple-dose antibiotic prophylaxis in penetrating trauma. Chemotherapy 1999; 45: 380–391.
- Morris WT. Effectiveness of ceftriaxone versus cefoxitin in reducing chest and wound infections after upper abdominal operations. Am J Surg 1994; 167: 391–395.
- Hall JC, Watts JM, Press L, O'Brien P, Turnidge J, McDonald P. Single-dose antibiotic prophylaxis in contaminat-ed abdominal surgery. Arch Surg 1989; 124: 244–247.
- Geroulanos S. Infectious complications and risks in abdominal surgery: early recognition and prevention. Hepatogastroenterology 1991; 38: 261–271.
- Lambert PA, Conway BR. Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin®. J Chemother 2003; 15: 357–368.